EurekaMag
+ Translate
+ Most Popular
Cunninghamia lanceolata plantations in China
Mammalian lairs in paleo ecological studies and palynology
Studies on technological possibilities in utilization of anhydrous milk fat for production of recombined butter-like products
Should right-sided fibroelastomas be operated upon?
Large esophageal lipoma
Apoptosis in the mammalian thymus during normal histogenesis and under various in vitro and in vivo experimental conditions
Poissons characoides nouveaux ou non signales de l'Ilha do Bananal, Bresil
Desensitizing efficacy of Colgate Sensitive Maximum Strength and Fresh Mint Sensodyne dentifrices
Administration of fluid by subcutaneous infusion: revival of a forgotten method
Tundra mosquito control - an impossible dream?
Schizophrenia for primary care providers: how to contribute to the care of a vulnerable patient population
Geochemical pattern analysis; method of describing the Southeastern limestone regional aquifer system
Incidence of low birth weights in a hospital of Mexico City
Tabanidae
Graded management intensity of grassland systems for enhancing floristic diversity
Microbiology and biochemistry of cheese and fermented milk
The ember tetra: a new pygmy characid tetra from the Rio das Mortes, Brazil, Hyphessobrycon amandae sp. n. (Pisces, Characoidei)
Risk factors of contrast-induced nephropathy in patients after coronary artery intervention
Renovation of onsite domestic wastewater in a poorly drained soil
Observations of the propagation velocity and formation mechanism of burst fractures caused by gunshot
Systolic blood pressure in a population of infants in the first year of life: the Brompton study
Haematological studies in rats fed with metanil yellow
Studies on pasteurellosis. I. A new species of Pasteurella encountered in chronic fowl cholera
Dormancy breaking and germination of Acacia salicina Lindl. seeds
therapy of lupus nephritis. a two-year prospective study

Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a


Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a



Brain: a Journal of Neurology 123: 116-124



ISSN/ISBN: 0006-8950

PMID: 10611126

DOI: 10.1093/brain/123.1.116

A retrospective case study of 33 Guillain-Barré syndrome (GBS) patients with the antibody to the ganglioside N-acetylgalactosaminyl GD1a (GalNAc-GD1a) was made to investigate the clinical features of GBS with this antibody. Patients were classified into three groups: (i) 25 with IgG antibody (group G, titre >/= 1 : 40); (ii) 16 with high-titre IgG antibody (group G-high, titre >/=1:320; selected from group G patients), and (iii) eight with IgM antibody but without elevation of IgG (group M, normal range <1:40 for both IgM and IgG). The control group consisted of 72 GBS patients without anti-GalNAc-GD1a antibody. Compared with the control group, the G-high and G group patients were characterized as having had antecedent gastrointestinal infection (87% and 72% versus 31%, both P < 0.001), uncommon cranial nerve involvement (19% and 36% versus 54%, P = 0.02 and 0.2, respectively), distal-dominant weakness (94% and 68% versus 36%, P < 0.001 and P = 0.01, respectively) and no sensory signs (81% and 60% versus 25%, P < 0.001 and P = 0.003, respectively). Electrophysiological findings indicative of axonal dysfunction were significantly more common in the G-high and G group patients (63% and 52% versus 14%, both P < 0.001). The pure motor variant that showed neither sensory signs nor abnormalities in sensory conduction studies was also more frequent in these groups (44% and 32% versus 9%, both P < 0.001). IgG anti-GalNAc-GD1a antibody may be a marker of the pure motor and the axonal variants of GBS, and therefore it, as well as anti-GM1 antibody, must be investigated in these forms in order to diagnose and understand the variants. By contrast, mild weakness, frequent facial palsy (75%) and a high incidence of IgM anti-GM2 antibody reactivity (88%) were characteristic of group M, indicating that the GBS in that group resulted from a different immune mechanism from that in the G group.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 046198767

Download citation: RISBibTeXText

Related references

Guillain-Barre syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 123(1): 116-124, 2000

N-acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Annals of Neurology 35(5): 570-576, 1994

Guillain-Barré syndrome-like-onset neurosarcoidosis positive for immunoglobulin G anti-N-acetylgalactosaminyl-GD1a antibody. Journal of Clinical Neuroscience: Official Journal of the Neurosurgical Society of Australasia 21(1): 170-172, 2014

A case of Guillain-Barré syndrome after Campylobacter jejuni enterocolitis: anti-ganglioside antibody levels with or without Guillain-Barré syndrome. Rinsho Shinkeigaku 41(9): 625-627, 2001

IgM anti-GM2 antibody in a patient with Guillain-Barré syndrome subsequent to cytomegalovirus hepatitis cross reacts with N-acetylgalactosaminyl GD1a. Journal of Neurology Neurosurgery and Psychiatry 65(3): 407-408, 1998

Mechanisms of Action of AntiGm 1 and AntiGq 1b Ganglioside Antibodies in Guillain Barr Syndrome. The Journal of Infectious Diseases 176(s2): S144-S149, 1997

A study on the mechanism of antigenantibody reaction increased by ganglioside-complex in Guillain Barr syndrome. Journal of Neuroimmunology 275(1-2): 47, 2014

More severe manifestations and poorer short-term prognosis of ganglioside-associated Guillain Barr syndrome in northeast China. Journal of Neuroimmunology 275(1-2): 49, 2014

Guillain-Barré syndrome with IgM antibody to the ganglioside GalNAc-GD1a. Journal of Neuroimmunology 113(2): 260-267, 2001

Correlations between cytomegalovirus, Epstein-Barr virus, anti-ganglioside antibodies, electrodiagnostic findings and functional status in Guillain-Barré syndrome. Iranian Journal of Neurology 13(1): 7-12, 2014

Etiological mechanism and treatment of Guillain-Barre syndrome-- Campylobacter jejuni enteritis and the development of anti-ganglioside antibody preceding the syndrome. Nihon Naika Gakkai Zasshi. Journal of the Japanese Society of Internal Medicine 87(4): 612-616, 1998

Serum antibody against a peripheral nerve myelin ganglioside, LM1, in Guillain-Barré syndrome. Journal of the Neurological Sciences 168(2): 85-89, 1999

Significance of serum antibody to GD1b ganglioside in patients with Guillain-Barré syndrome. Indian Journal of Medical Research 113: 234-238, 2001

Significance of serum antibody to GD1b ganglioside in patients with Guillain-Barre syndrome. Indian Journal of Medical Research 113(June): 234-238, 2001

Fulminant Guillain-Barrè syndrome after Campylobacter jejuni enteritis and anti-ganglioside antibody. Internal Medicine 41(10): 760-761, 2002